Penetration Depth: How Deep Does Red Light Go?

“Our device penetrates 3 inches into tissue.” You will see claims like this across red light therapy marketing. They sound impressive, but they obscure a more nuanced reality. Penetration depth is not a single number — it depends on wavelength, tissue type, skin pigmentation, irradiance, and critically, what you define as “penetration.”

Understanding what actually happens when photons enter human tissue is essential for choosing the right device and setting realistic expectations.

The Optical Window: Why 600-1100nm Matters

Human tissue is not uniformly transparent or opaque. It has wavelength-dependent absorption and scattering properties. Two major absorbers dominate:

Haemoglobin (oxygenated and deoxygenated) — absorbs strongly below 600nm. This is why blue and green light barely penetrate skin
Water — absorbs strongly above 1100nm. This is why far-infrared light is absorbed almost entirely in the first millimetres of tissue

Between roughly 600nm and 1100nm lies the “optical window” or “therapeutic window” — a range where neither haemoglobin nor water absorbs efficiently, allowing photons to travel deeper into tissue. This is precisely the range used in photobiomodulation: red light (620-700nm) and near-infrared (700-1100nm).

Within this window, penetration is not uniform. Near-infrared wavelengths around 800-850nm sit at the sweet spot where both haemoglobin and water absorption are minimal, giving them the deepest penetration of any wavelength used in PBM.

Penetration by Wavelength

The following data is drawn from multiple studies using human and animal tissue, including the seminal work by Esnouf et al. (2007), Kolari (1985), and Henderson and Morries (2015):

Wavelength	Typical Penetration (50% intensity)	Typical Penetration (1% intensity)	Primary Absorbers
630nm (red)	1-3mm	6-10mm	Haemoglobin, melanin
660nm (red)	2-4mm	8-15mm	Haemoglobin (reduced), melanin
810nm (NIR)	5-10mm	20-30mm	Minimal absorption
850nm (NIR)	5-10mm	20-40mm	Minimal absorption
940nm (NIR)	3-6mm	15-25mm	Water absorption increasing
1064nm (NIR)	2-5mm	10-20mm	Water absorption significant

Critical distinction: The “50% intensity” column represents the depth at which half the surface irradiance remains — this is the depth at which meaningful photobiomodulation occurs. The “1% intensity” column represents the depth at which only 1% of surface photons survive — enough to detect with sensitive instruments but likely insufficient for therapeutic effect.

When manufacturers claim “penetration up to 3 inches” (75mm), they are typically referring to the absolute depth at which any photon can be detected, not the depth at which a therapeutic dose is delivered. These are very different things.

Factors That Affect Penetration

Skin Pigmentation (Melanin)

Melanin is a broadband absorber that reduces light transmission across the entire optical window. Darker skin absorbs significantly more incident light before it reaches deeper tissues.

Bashkatov et al. (2005) quantified this in a study of human skin optical properties (Journal of Physics D: Applied Physics). For 850nm light, increasing melanin concentration from Fitzpatrick Type I (very fair) to Type VI (very dark) can reduce transmitted intensity by 40-60% at any given depth (PMID: N/A — J Phys D Appl Phys 38:2543-2555).

Practical implication: People with darker skin should use higher irradiance devices, position the device closer to the skin, and consider extending treatment time by 25-50% to compensate for melanin absorption.

Tissue Type

Not all tissue attenuates light equally:

Skin (epidermis + dermis): Strong scattering and moderate absorption. The first 1-2mm is where most photon loss occurs
Subcutaneous fat: Relatively transparent to NIR light. Fat scatters but does not absorb strongly at 850nm. However, thick fat layers increase the path length photons must travel
Muscle: Moderate absorption due to myoglobin (structurally similar to haemoglobin). Penetration through muscle is reduced compared with fat
Bone: Cortical bone is a significant barrier. Transcranial studies show that 810nm light loses approximately 95-97% of its intensity passing through the human skull (Jagdeo et al., 2012, Journal of Biophotonics; PMID: 22933407)
Blood: Highly absorptive. Vascularised tissue attenuates light more than avascular tissue. This is why tendon and cartilage (poorly vascularised) may receive proportionally more light than surrounding muscle

Irradiance and Power

Higher surface irradiance means more photons enter the tissue, and more photons survive to deeper layers. This is a linear relationship: doubling the irradiance at the surface doubles the number of photons reaching any given depth (assuming the tissue properties are unchanged).

This is why device power matters for deep-tissue applications. A 30mW/cm² device and a 150mW/cm² device have the same percentage attenuation through tissue, but the higher-power device delivers five times more energy at depth.

Beam Coherence: LED vs Laser

Laser light is coherent (parallel, same phase) whilst LED light is incoherent (divergent, random phase). This distinction affects penetration in two ways:

Collimation: Laser beams spread less as they enter tissue, maintaining higher intensity along the central axis. LED light diverges immediately, distributing energy across a wider volume
Speckle effect: Coherent laser light creates interference patterns (speckle) within tissue that may produce localised intensity peaks deeper than the average penetration. Whether this translates to clinical advantage is debated

In practice, the difference between laser and LED penetration is smaller than often claimed. Scattering in tissue rapidly disrupts laser coherence within the first few millimetres, so by the time light reaches 10-20mm depth, both sources behave similarly. The primary advantage of lasers is the ability to concentrate higher irradiance into a small spot, not fundamentally deeper penetration.

How Penetration Is Measured

Cadaver Studies

The traditional method: shine a light source on one side of excised human tissue and measure what emerges on the other side using a photodetector or integrating sphere. Kolari (1985) and Esnouf et al. (2007) used this approach with human skin samples of known thickness.

Limitations: Cadaver tissue lacks blood flow, which significantly affects absorption (no circulating haemoglobin). Results tend to overestimate penetration compared with living tissue. Tissue also changes optical properties post-mortem as cellular structures break down.

In Vivo Measurements

More clinically relevant but technically challenging. Researchers place photodetectors beneath or behind tissue in living subjects. Jagdeo et al. (2012) measured light transmission through the human skull by placing a photodetector inside cadaver skulls, then validated with in vivo transcranial measurements.

Henderson and Morries (2015) used a fibre optic probe inserted into deep tissue during neurosurgery to measure 810nm light intensity at various depths from an external source, providing some of the best in vivo data available (Journal of Neurological Research; PMID: 25635586).

Computational Modelling

Monte Carlo simulations model photon transport through tissue by simulating millions of individual photon paths, accounting for absorption, scattering, and reflection at each step. These models can predict intensity distributions at any depth for any wavelength and tissue combination.

Computational models generally agree with experimental measurements but are only as good as their input parameters (tissue optical properties), which vary between individuals and are imperfectly characterised.

Why “Deep Penetration” Claims Need Scrutiny

The Detection vs Therapy Problem

Manufacturers often conflate detection and therapy. With a sensitive enough photodetector, you can measure individual photons that have passed through several centimetres of tissue. But detecting a photon is not the same as delivering a therapeutic dose.

Photobiomodulation requires sufficient energy density (fluence) at the target tissue to trigger biological effects — typically 1-50 J/cm² depending on the application, according to the Arndt-Schulz curve and biphasic dose response model (Huang et al., 2009, Dose-Response; PMID: 20011653).

If 99.9% of photons are absorbed or scattered before reaching the target, the remaining 0.1% may be detectable but therapeutically meaningless unless the surface irradiance is extraordinarily high.

The Measurement Distance Problem

Some manufacturers measure penetration through thin tissue samples (1-2mm skin sections) and extrapolate to whole-body applications. A device that transmits 80% of light through a 1mm skin sample does not transmit 80% through 10mm of intact tissue with subcutaneous fat and muscle — attenuation is exponential, not linear.

What “Penetrates to Bone” Actually Means

For knee treatment, “penetrating to bone” requires reaching approximately 15-40mm depth through skin, fat, muscle, and joint capsule. At 850nm with a 100mW/cm² device:

At 5mm depth: approximately 30-50mW/cm² remains (enough for therapeutic effect)
At 15mm depth: approximately 3-10mW/cm² remains (marginal but potentially therapeutic)
At 30mm depth: approximately 0.3-1mW/cm² remains (likely subtherapeutic for most applications)
At 50mm depth: approximately 0.01-0.1mW/cm² remains (detectable but almost certainly insufficient)

These are approximate values — individual variation in tissue composition creates wide ranges. But they illustrate why treating deep joints like the hip (50-80mm) with consumer LED panels is fundamentally challenging.

Practical Implications for Device Selection

For Skin Conditions (Wrinkles, Acne, Wound Healing)

Target depth: 0-3mm. Both 630-660nm red and 850nm NIR penetrate easily to dermal layers. Any quality device will work. Irradiance requirements are modest — even 30mW/cm² is adequate with sufficient treatment time.

For Superficial Joints (Fingers, Wrists, Ankles)

Target depth: 5-20mm. Use 850nm for better penetration. Moderate irradiance devices (50-100mW/cm²) are sufficient. Hand joints respond well even to lower-powered devices due to minimal overlying tissue.

For Deep Joints (Knees, Shoulders)

Target depth: 15-40mm. Use 850nm with the highest available irradiance. Position the device as close to the skin as possible (contact or near-contact). Treatment times of 10-15 minutes are typically needed.

For Very Deep Structures (Hips, Spine)

Target depth: 40-80mm. Consumer LED panels are unlikely to deliver therapeutic doses at this depth. Consider:

Professional class 3B/4 laser treatment
Accepting that treatment may benefit surrounding soft tissue without reaching the deep joint itself
Using the highest-power consumer device available and treating for extended periods (15-20 minutes)

For Brain (Transcranial PBM)

Target depth: 15-25mm through skull bone. The skull absorbs 95-97% of incident light. Only purpose-built transcranial devices with high irradiance directed at thinned cranial regions (temporal, frontal) are appropriate. Standard body panels held to the head deliver negligible intracranial doses.

The Inverse Square Law Does Not Apply

A common misconception is that light intensity from an LED panel follows the inverse square law (intensity drops proportionally to distance squared). This law applies to point sources in free space, not to light entering tissue.

Inside tissue, attenuation follows Beer-Lambert law modified for scattering — essentially exponential decay. The rate of decay depends on the tissue’s absorption and scattering coefficients at the specific wavelength.

The inverse square law does apply to the air gap between your device and your skin. Doubling the distance from 3 inches to 6 inches reduces irradiance at the skin surface by approximately 4x. This is why positioning matters: treat as close to the skin as comfortable.

Summary

Light penetration is real, measurable, and wavelength-dependent. Near-infrared at 810-850nm penetrates deepest within the therapeutic window, reaching meaningful intensities at 10-20mm in most tissue types. Red light at 630-660nm penetrates to approximately 5-10mm and is well-suited for skin and superficial structures.

Be sceptical of extreme penetration claims. What matters is not whether a photon can be detected at depth, but whether a therapeutic dose arrives there. For superficial targets (skin, tendons, hand joints), most quality devices deliver adequate doses. For deep targets (hips, brain), the physics of tissue absorption presents fundamental challenges that no amount of marketing can overcome.

Choose your wavelength and device power based on the depth of your target tissue, and adjust your expectations accordingly.

References

Bashkatov AN, et al. Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range 400 to 2000nm. J Phys D Appl Phys. 2005;38:2543-2555
Jagdeo JR, et al. Transcranial red and near infrared light transmission in a cadaveric model. PLoS One. 2012;7(10):e47460. PMID: 22933407
Henderson TA, Morries LD. Near-infrared photonic energy penetration: can infrared phototherapy effectively reach the human brain? Neuropsychiatr Dis Treat. 2015;11:2191-2208. PMID: 25635586
Huang YY, et al. Biphasic dose response in low level light therapy. Dose Response. 2009;7(4):358-383. PMID: 20011653
Esnouf A, et al. Depth of penetration of an 850nm wavelength low level laser in human skin. Acupunct Electrother Res. 2007;32(1-2):81-86
Kolari PJ. Penetration of unfocused laser light into the skin. Arch Dermatol Res. 1985;277(4):342-344